Cancer Research TCM Europe Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Agathanggelou, A.
Right arrow Articles by Latif, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Agathanggelou, A.
Right arrow Articles by Latif, F.
Related Collections
Right arrow Cellular Pathobiology
Right arrow Cellular Pathobiology: Cancer Genes and Genomics
[Cancer Research 65, 3497-3508, May 1, 2005]
© 2005 American Association for Cancer Research

Reviews

Role of the Ras-Association Domain Family 1 Tumor Suppressor Gene in Human Cancers

Angelo Agathanggelou, Wendy N. Cooper and Farida Latif

Section of Medical and Molecular Genetics, Division of Reproductive and Child Health, The Institute of Biomedical Research, University of Birmingham, Edgbaston, Birmingham, United Kingdom

Requests for reprints: Farida Latif, Section of Medical and Molecular Genetics, Division of Reproductive and Child Health, The Institute of Biomedical Research, University of Birmingham, Edgbaston, Birmingham, B15 2TT, United Kingdom. Phone: 44-121-627-2741; Fax: 44-121-627-2618; E-mail: flatif{at}hgmp.mrc.ac.uk.

In recent years, the list of tumor suppressor genes (or candidate TSG) that are inactivated frequently by epigenetic events rather than classic mutation/deletion events has been growing. Unlike mutational inactivation, methylation is reversible and demethylating agents and inhibitors of histone deacetylases are being used in clinical trails. Highly sensitive and quantitative assays have been developed to assess methylation in tumor samples, early lesions, and bodily fluids. Hence, gene silencing by promoter hypermethylation has potential clinical benefits in early cancer diagnosis, prognosis, treatment, and prevention. The hunt for a TSG located at 3p21.3 resulted in the identification of the RAS-association domain family 1, isoform A gene (RASSF1A). RASSF1A falls into the category of genes frequently inactivated by methylation rather than mutational events. This gene is silenced and frequently inactivated by promoter region hypermethylation in many adult and childhood cancers, including lung, breast, kidney, gastric, bladder, neuroblastoma, medulloblastoma, gliomas and it has homology to a mammalian Ras effector (i.e., Nore1). RASSF1A inhibits tumor growth in both in vitro and in vivo systems, further supporting its role as a TSG. We and others identified the gene in 2000, but already there are over a 150 publications demonstrating RASSF1A methylation in a large number of human cancers. Many laboratories including ours are actively investigating the biology of this novel protein family. Thus far, it has been shown to play important roles in cell cycle regulation, apoptosis, and microtubule stability. This review summarizes our current knowledge on genetic, epigenetic, and functional analysis of RASSF1A tumor suppressor gene and its homologues.




This article has been cited by other articles:


Home page
 Cancer Res.Home page
D. Romano, D. Matallanas, G. Weitsman, C. Preisinger, T. Ng, and W. Kolch
Proapoptotic Kinase MST2 Coordinates Signaling Crosstalk between RASSF1A, Raf-1, and Akt
Cancer Res., February 1, 2010; 70(3): 1195 - 1203.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
Y. C. Antill, G. Mitchell, S. A. Johnson, L. Devereux, A. Milner, J. Di Iulio, G. J. Lindeman, J. Kirk, K. A. Phillips, and I. G. Campbell
Gene Methylation in Breast Ductal Fluid from BRCA1 and BRCA2 Mutation Carriers
Cancer Epidemiol. Biomarkers Prev., January 1, 2010; 19(1): 265 - 274.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
Y. Kawai, S. Sakano, Y. Suehiro, T. Okada, Y. Korenaga, T. Hara, K. Naito, H. Matsuyama, and Y. Hinoda
Methylation level of the RASSF1A promoter is an independent prognostic factor for clear-cell renal cell carcinoma
Ann. Onc., December 27, 2009; (2009) mdp577v1.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
H. Yazici, M. B. Terry, Y. H. Cho, R. T. Senie, Y. Liao, I. Andrulis, and R. M. Santella
Aberrant Methylation of RASSF1A in Plasma DNA Before Breast Cancer Diagnosis in the Breast Cancer Family Registry
Cancer Epidemiol. Biomarkers Prev., October 1, 2009; 18(10): 2723 - 2725.
[Abstract] [Full Text] [PDF]

Home page
 Sci SignalHome page
M. Ikeda, A. Kawata, M. Nishikawa, Y. Tateishi, M. Yamaguchi, K. Nakagawa, S. Hirabayashi, Y. Bao, S. Hidaka, Y. Hirata, et al.
Hippo Pathway-Dependent and -Independent Roles of RASSF6
Sci. Signal., September 29, 2009; 2(90): ra59 - ra59.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. F. Calvisi, H. Donninger, M. D. Vos, M. J. Birrer, L. Gordon, V. Leaner, and G. J. Clark
NORE1A Tumor Suppressor Candidate Modulates p21CIP1 via p53
Cancer Res., June 1, 2009; 69(11): 4629 - 4637.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. J. Song, M. S. Song, S. J. Kim, S. Y. Kim, S. H. Kwon, J. G. Kim, D. F. Calvisi, D. Kang, and D.-S. Lim
Aurora A Regulates Prometaphase Progression by Inhibiting the Ability of RASSF1A to Suppress APC-Cdc20 Activity
Cancer Res., March 15, 2009; 69(6): 2314 - 2323.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Thaler, P. S. Hahnel, A. Schad, R. Dammann, and M. Schuler
RASSF1A Mediates p21Cip1/Waf1-Dependent Cell Cycle Arrest and Senescence through Modulation of the Raf-MEK-ERK Pathway and Inhibition of Akt
Cancer Res., March 1, 2009; 69(5): 1748 - 1757.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. Macheiner, C. Gauglhofer, C. Rodgarkia-Dara, M. Grusch, A. Brachner, C. Bichler, D. Kandioler, H. Sutterluty, W. Mikulits, R. Schulte-Hermann, et al.
NORE1B Is a Putative Tumor Suppressor in Hepatocarcinogenesis and May Act via RASSF1A
Cancer Res., January 1, 2009; 69(1): 235 - 242.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
B. C. Christensen, J. J. Godleski, C. J. Marsit, E. A. Houseman, C. Y. Lopez-Fagundo, J. L. Longacker, R. Bueno, D. J. Sugarbaker, H. H. Nelson, and K. T. Kelsey
Asbestos exposure predicts cell cycle control gene promoter methylation in pleural mesothelioma
Carcinogenesis, August 1, 2008; 29(8): 1555 - 1559.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Zhang, G. A. Smolen, and D. A. Haber
Negative Regulation of YAP by LATS1 Underscores Evolutionary Conservation of the Drosophila Hippo Pathway
Cancer Res., April 15, 2008; 68(8): 2789 - 2794.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
V. Sherwood, R. Manbodh, C. Sheppard, and A. D. Chalmers
RASSF7 Is a Member of a New Family of RAS Association Domain-containing Proteins and Is Required for Completing Mitosis
Mol. Biol. Cell, April 1, 2008; 19(4): 1772 - 1782.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
B. Ding and P. Lengyel
p204 Protein Is a Novel Modulator of Ras Activity
J. Biol. Chem., February 29, 2008; 283(9): 5831 - 5848.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
B. Gao, X.-J. Xie, C. Huang, D. S. Shames, T. T-L. Chen, C. M. Lewis, A. Bian, B. Zhang, O. I. Olopade, J. E. Garber, et al.
RASSF1A Polymorphism A133S Is Associated with Early Onset Breast Cancer in BRCA1/2 Mutation Carriers
Cancer Res., January 1, 2008; 68(1): 22 - 25.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Miertzschke, P. Stanley, T. D. Bunney, F. Rodrigues-Lima, N. Hogg, and M. Katan
Characterization of Interactions of Adapter Protein RAPL/Nore1B with RAP GTPases and Their Role in T Cell Migration
J. Biol. Chem., October 19, 2007; 282(42): 30629 - 30642.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
H. Donninger, M. D. Vos, and G. J. Clark
The RASSF1A tumor suppressor
J. Cell Sci., September 15, 2007; 120(18): 3163 - 3172.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
U. Lehmann, L. U. Wingen, K. Brakensiek, H. Wedemeyer, T. Becker, A. Heim, K. Metzig, B. Hasemeier, H. Kreipe, and P. Flemming
Epigenetic defects of hepatocellular carcinoma are already found in non-neoplastic liver cells from patients with hereditary haemochromatosis
Hum. Mol. Genet., June 1, 2007; 16(11): 1335 - 1342.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
E. Hwang, K.-S. Ryu, K. Paakkonen, P. Guntert, H.-K. Cheong, D.-S. Lim, J.-O. Lee, Y. H. Jeon, and C. Cheong
Structural insight into dimeric interaction of the SARAH domains from Mst1 and RASSF family proteins in the apoptosis pathway
PNAS, May 29, 2007; 104(22): 9236 - 9241.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
I. Perez de Castro, G. de Carcer, and M. Malumbres
A census of mitotic cancer genes: new insights into tumor cell biology and cancer therapy
Carcinogenesis, May 1, 2007; 28(5): 899 - 912.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
N. L. Lehman, R. Tibshirani, J. Y. Hsu, Y. Natkunam, B. T. Harris, R. B. West, M. A. Masek, K. Montgomery, M. van de Rijn, and P. K. Jackson
Oncogenic Regulators and Substrates of the Anaphase Promoting Complex/Cyclosome Are Frequently Overexpressed in Malignant Tumors
Am. J. Pathol., May 1, 2007; 170(5): 1793 - 1805.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K. Kawamoto, S. T. Okino, R. F. Place, S. Urakami, H. Hirata, N. Kikuno, T. Kawakami, Y. Tanaka, D. Pookot, Z. Chen, et al.
Epigenetic Modifications of RASSF1A Gene through Chromatin Remodeling in Prostate Cancer
Clin. Cancer Res., May 1, 2007; 13(9): 2541 - 2548.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
J. Geli, N. Kiss, F. Lanner, T. Foukakis, N. Natalishvili, O. Larsson, P. Kogner, A. Hoog, G. J Clark, T. J Ekstrom, et al.
The Ras effectors NORE1A and RASSF1A are frequently inactivated in pheochromocytoma and abdominal paraganglioma
Endocr. Relat. Cancer, March 1, 2007; 14(1): 125 - 134.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
R. W.K. Chiu, S. S.C. Chim, I. H.N. Wong, C. S.C. Wong, W.-S. Lee, K. F. To, J. H.M. Tong, R. K.C. Yuen, A. S.W. Shum, J. K.C. Chan, et al.
Hypermethylation of RASSF1A in Human and Rhesus Placentas
Am. J. Pathol., March 1, 2007; 170(3): 941 - 950.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
E. Estrabaud, I. Lassot, G. Blot, E. Le Rouzic, V. Tanchou, E. Quemeneur, L. Daviet, F. Margottin-Goguet, and R. Benarous
RASSF1C, an Isoform of the Tumor Suppressor RASSF1A, Promotes the Accumulation of {beta}-Catenin by Interacting with {beta}TrCP
Cancer Res., February 1, 2007; 67(3): 1054 - 1061.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Dallol, W. N. Cooper, F. Al-Mulla, A. Agathanggelou, E. R. Maher, and F. Latif
Depletion of the Ras Association Domain Family 1, Isoform A-Associated Novel Microtubule-Associated Protein, C19ORF5/MAP1S, Causes Mitotic Abnormalities
Cancer Res., January 15, 2007; 67(2): 492 - 500.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
D. W. Heilman, J. G. Teodoro, and M. R. Green
Apoptin Nucleocytoplasmic Shuttling Is Required for Cell Type-Specific Localization, Apoptosis, and Recruitment of the Anaphase-Promoting Complex/Cyclosome to PML Bodies
J. Virol., August 1, 2006; 80(15): 7535 - 7545.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Moshnikova, J. Frye, J. W. Shay, J. D. Minna, and A. V. Khokhlatchev
The Growth and Tumor Suppressor NORE1A Is a Cytoskeletal Protein That Suppresses Growth by Inhibition of the ERK Pathway
J. Biol. Chem., March 24, 2006; 281(12): 8143 - 8152.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
K. Yano, K. Imai, A. Shimizu, and T. Hanashita
A new method for gene discovery in large-scale microarray data
Nucleic Acids Res., March 14, 2006; 34(5): 1532 - 1539.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. D. Vos, A. Dallol, K. Eckfeld, N. P. C. Allen, H. Donninger, L. B. Hesson, D. Calvisi, F. Latif, and G. J. Clark
The RASSF1A Tumor Suppressor Activates Bax via MOAP-1
J. Biol. Chem., February 24, 2006; 281(8): 4557 - 4563.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Dallol, A. Agathanggelou, S. Tommasi, G. P. Pfeifer, E. R. Maher, and F. Latif
Involvement of the RASSF1A Tumor Suppressor Gene in Controlling Cell Migration
Cancer Res., September 1, 2005; 65(17): 7653 - 7659.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
RASSF1 Tumor Suppressor Gene
Cancer Res., June 15, 2005; 65(12): 5480 - 5480.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.